TriSalus Life Sciences's total assets for Q2 2024 were $32.43M, an increase of 81.29% from the previous quarter. TLSI total liabilities were $56.58M for the fiscal quarter, a 7.13% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.